Folate, cobalamin, cysteine, homocysteine, and Arsenic metabolism among children in Bangladesh

Environmental Health Perspectives

Volumn 117, Issue 5, 2009, Pages 825-831

  Hall, Megan N ^a   Liu, Xinhua ^a   Slavkovich, Vesna ^a   Ilievski, Vesna ^a   Pilsner, J Richard ^b   Alam, Shafiul ^a   Factor Litvak, Pam ^a   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Och Spine at New York Presbyterian Hospitals   (Bangladesh)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Arsenic; Bangladesh; Children; Cobalamin; Creatinine; Cysteine; Dimethylarsinic acid; Folate; Homocysteine; Monomethylarsonic acid; One carbon metabolism

Indexed keywords

ARSENIC ACID; CACODYLIC ACID; COBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METHANEARSONIC ACID;

ARTICLE; BANGLADESH; BLOOD SAMPLING; CARBON METABOLISM; CHILD; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; UPREGULATION; URINALYSIS; URINARY EXCRETION;

ARSENIC; CHILD; CYSTEINE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LINEAR MODELS; MALE; SEX FACTORS; VITAMIN B 12; WATER POLLUTANTS, RADIOACTIVE;

EID: 66349087609     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800164     Document Type: Article

References (55)

1. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16(6):1270-1278.
2. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 16(2):191-205.
3. Bates CJ, Mansoor MA, Gregory J, Pentiev K, Prentice A. 2002. Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. Br J Nutr 87(1):71-79.
4. California Environmental Protection Agency. 2004. Public Health Goals for Arsenic in Drinking Water. Sacramento:California Environmental Protection Agency, Office of Environmental Health Hazard Assessment.
5. Carmel R, Mallidi PV, Vinarskiy S, Brar S, Frouhar Z. 2002. Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States. Am J Hematol 70(2):107-114.
6. Celkova A, Kubova J, Stresko V. 1996. Determination of arsenic in geological samples by HG AAS. Anal Bioanal Chem 355(2):150-153.
7. Chambers JC, Obeid OA, Refsum H, Ueland P, Hackett D, Hooper J, et al. 2000. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355(9203):523-527.
8. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45(3):241-248.
9. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14(4):303-310.
10. Cheng Z, Zheng Y, Mortlock R, Van Geen A. 2004. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem 379(3):512-518.
11. Chowdhury UK, Rahman MM, Sengupta MK, Lodh D, Chanda CR, Roy S, et al. 2003. Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng 38(1):87-113.
12. 12 and folate determination compared in a reference interval study. Clin Chem 31(8):1358-1360.
13. Concha G, Nermell B, Vahter MV. 1998. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect 106:355-359.
14. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. 2007. Development of a WHO growth reference for school-aged children and adolescents. Bull WHO 85(9):660-667.
15. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. 2005a. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr 81(6):1372-1377.
16. Gamble MV, Liu X. 2005. Urinary creatinine and arsenic metabolism [Letter]. Environ Health Perspect 113:A442-443.
17. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, et al. 2006. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr 84(5):1093-1101.
18. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. 2005b. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683-1688.
19. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P, et al. 2007. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 86(4):1202-1209.
20. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. 2007. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect 115:1503-1509.
21. Heady JE, Kerr SJ. 1975. Alteration of glycine N-methyl-transferase activity in fetal, adult, and tumor tissues. Cancer Res 35:640-643.
22. Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, et al. 2008. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 19(8):829-839.
23. IARC (International Agency for Research on Cancer). 2004. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risk Hum 84:41-267.
24. Jones DP, Go YM, Anderson CL, Ziegler TR, Kinkade JM Jr, Kirlin WG. 2004. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 18(11):1246-1248.
25. Kinniburgh DG, Smedley PL. 2001. Arsenic Contamination of Groundwater in Bangladesh. Final Report. BGS Technical Report. Keyworth, UK:British Geological Survey.
26. Korzun WJ. 2004. Oral creatine supplements lower plasma homocysteine concentrations in humans. Clin Lab Sci 17(2):102-106.
27. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2002. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11(246):1-190.
28. Marafante E, Vahter M. 1984. The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem Biol Interact 50(1):49-57.
29. Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, et al. 2005. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. Environ Health Perspect 113:775-781.
30. Mudd SH, Poole JR. 1975. Labile methyl balances for normal humans on various dietary regimens. Metabolism 24(6):721-735.
31. Must A, Jacques PF, Rogers G, Rosenberg IH, Selhub J. 2003. Serum total homocysteine concentrations in children and adolescents: results from the third National Health and Nutrition Examination Survey (NHANES III). J Nutr 133(8):2643-2649.
32. Navarro Silvera SA, Rohan TE. 2007. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control 18(1):7-27.
33. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37(9):1575-1579.
34. Papandreou D, Mavromichalis I, Makedou A, Rousso I, Arvanitidou M. 2006. Reference range of total serum homocysteine level and dietary indexes in healthy Greek schoolchildren aged 6-15 years. Br J Nutr 96(4):719-724.
35. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. 2005. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82(2):442-450.
36. Pfeiffer CM, Huff DL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45(2):290-292.
37. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. 2007. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 86(3):718-727.
38. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. 2008. Folate deficiency, hyperhomocysteinemia, low urinary creatinine and hypomethylation of leukocyte DNA are independent risk factors for arsenic-induced skin lesions. Environ Health Perspect 117:254-260.
39. Slot C. 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17(4):381-387.
40. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296.
41. Spiegelstein O, Lu X, Le XC, Troen A, Selhub J, Melnyk S, et al. 2003. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 145(2):167-174.
42. Stead LM, Au KP, Jacobs RL, Brosnan ME, Brosnan JT. 2001. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am J Physiol Endocrinol Metab 281(5):E1095-E1100.
43. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. 2006. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 83(1):5-10.
44. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110(suppl 5):767-771.
45. Sun G, Xu Y, Li X, Jin Y, Li B, Sun X. 2007. Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China. Environ Health Perspect 115:648-652.
46. Taes YE, Delanghe JR, De Vriese AS, Rombaut R, Van Camp J, Lameire NH. 2003. Creatine supplementation decreases homocysteine in an animal model of uremia. Kidney Int 64(4):1331-1337.
47. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206(3):299-308.
48. U.S. EPA. 2001. National primary drinking water regulations: arsenic and clarifications to compliance and new source contaminants monitoring. Final Rule. Fed Reg. 66(14):6975-7066.
49. Vahter M, Marafante E. 1987. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37(1):41-46.
50. Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, et al. 2002. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull WHO 80(9):732-737.
51. Wang TC, Jan KY, Wang AS, Gurr JR. 2007. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat Res 615(1-2):75-86.
52. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115:285-289.
53. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112:1329-1333.
54. WHO. 2004. Guidelines for Drinking Water Quality. 3rd ed. Vol 1. Recommendations. Geneva:World Health Organization.
55. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166(12):1381-1391.